扩展标准 捐赠者心脏整体移植利用:国家趋势和结果
Syed Shahyan Bakhtiyar1, Sara Sakowitz1, Arjun Verma1
1Cardiovascular Outcomes Research Laboratories (CORELAB), University of California, Los Angeles, Los Angeles, California.
The Annals of thoracic surgery
|September 22, 2023
概括
大量心脏移植中心使用扩展标准捐赠器官来改善存活率. 这些中心表明,利用更多来自扩大标准捐赠者的器官不会对患者的结果产生负面影响.
科学领域:
- 心脏病学 心脏病学
- 移植医学 移植医学
- 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器
背景情况:
- 心脏移植越来越多地使用来自扩大标准捐赠者的器官.
- 在接受和利用这些所有移植的过程中,存在中心级别的变化.
- 评估与扩展标准捐赠器官相关的结果对于优化移植策略至关重要.
研究的目的:
- 调查最近使用扩展标准供体器官进行心脏移植的趋势.
- 分析接受扩展标准的中心特定变异.
- 评估与这些器官相关的移植后结果.
主要方法:
- 从器官采购和移植网络数据库中确定了一个成年心脏移植接受者队列 (2011-2022年).
- 扩展标准 通过验证的风险评分来定义所有移植.
- 中心按体积分层,并根据他们使用扩展的标准 (高,中,低) 进行分类.
主要成果:
- 在23,290例心脏移植中,有22%使用了扩展标准供体全移植.
- 高体积中心 (每年≥23例移植) 完成了72%的移植手术.
- 在大批量中心的移植与1年和5年的死亡率降低有关 (HR 0.78,P=.01;HR 0.85,P=.02).
结论:
- 在大量心脏移植中心使用扩大标准的捐赠者全移植显著提高了患者的生存率.
- 高容量中心可以安全地增加扩展标准器官的使用,而不会影响患者的治疗结果.
- 这些发现支持在经验丰富,高体积的移植机构中战略性地使用扩展标准供体器官.
更多相关视频
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
777
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
1.8K
相关概念视频
Kidney Transplant I: Introduction
14
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
14
Tissue Transplantation
391
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
391
